Alexandre Loupy

18.6k total citations · 4 hit papers
153 papers, 7.9k citations indexed

About

Alexandre Loupy is a scholar working on Transplantation, Surgery and Nephrology. According to data from OpenAlex, Alexandre Loupy has authored 153 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 117 papers in Transplantation, 87 papers in Surgery and 33 papers in Nephrology. Recurrent topics in Alexandre Loupy's work include Renal Transplantation Outcomes and Treatments (116 papers), Transplantation: Methods and Outcomes (64 papers) and Renal Diseases and Glomerulopathies (31 papers). Alexandre Loupy is often cited by papers focused on Renal Transplantation Outcomes and Treatments (116 papers), Transplantation: Methods and Outcomes (64 papers) and Renal Diseases and Glomerulopathies (31 papers). Alexandre Loupy collaborates with scholars based in France, United States and Canada. Alexandre Loupy's co-authors include Carmen Lefaucheur, Gary S. Hill, Denis Glotz, Christophe Legendre, Dominique Nochy, Xavier Jouven, Jean–Paul Duong Van Huyen, Dominique Charron, Olivier Aubert and Patrick Bruneval and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Alexandre Loupy

141 papers receiving 7.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival

2013 621 citations Alexandre Loupy, Carmen Lefaucheur et al. profile →
Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney Transplantation

2010 610 citations Carmen Lefaucheur, Alexandre Loupy et al. Journal of the American Society of Nephrology profile →
A 2018 Reference Guide to the Banff Classification of Renal Allograft Pathology

2018 482 citations Alexandre Loupy, Marion Rabant et al. Transplantation profile →
Antibody-Mediated Rejection of Solid-Organ Allografts

2018 349 citations Alexandre Loupy, Carmen Lefaucheur profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alexandre Loupy France	44	6.1k	3.9k	2.1k	1.8k	1.2k	153	7.9k
B. Sis Canada	44	5.6k 0.9×	3.4k 0.9×	2.0k 1.0×	1.8k 1.0×	833 0.7×	97	7.3k
Denis Glotz France	50	6.0k 1.0×	3.8k 1.0×	2.2k 1.0×	2.2k 1.2×	1.2k 1.0×	206	9.0k
Carmen Lefaucheur France	37	4.4k 0.7×	2.7k 0.7×	1.6k 0.8×	1.5k 0.8×	881 0.7×	94	5.7k
Daniel Serón Spain	43	3.6k 0.6×	2.2k 0.6×	1.6k 0.8×	869 0.5×	947 0.8×	226	6.1k
Magali Giral France	44	4.0k 0.7×	2.4k 0.6×	565 0.3×	1.9k 1.0×	933 0.8×	187	6.4k
Edward Cole Canada	44	3.2k 0.5×	2.5k 0.6×	1.1k 0.5×	467 0.3×	1.3k 1.0×	127	6.2k
Bernd Döhler Germany	37	3.4k 0.6×	2.2k 0.6×	600 0.3×	749 0.4×	886 0.7×	103	5.2k
J. Michael Cecka United States	42	4.7k 0.8×	3.9k 1.0×	835 0.4×	747 0.4×	2.9k 2.4×	123	7.0k
Claudia Sommerer Germany	35	2.2k 0.4×	1.1k 0.3×	1.1k 0.5×	400 0.2×	410 0.3×	164	4.6k
Kazunari Tanabe Japan	40	1.6k 0.3×	1.9k 0.5×	872 0.4×	951 0.5×	709 0.6×	376	5.6k

Countries citing papers authored by Alexandre Loupy

Since Specialization

Citations

This map shows the geographic impact of Alexandre Loupy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandre Loupy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandre Loupy more than expected).

Fields of papers citing papers by Alexandre Loupy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandre Loupy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandre Loupy. The network helps show where Alexandre Loupy may publish in the future.

Co-authorship network of co-authors of Alexandre Loupy

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandre Loupy. A scholar is included among the top collaborators of Alexandre Loupy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandre Loupy. Alexandre Loupy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Loupy, Alexandre, et al.. (2025). Reshaping transplantation with AI, emerging technologies and xenotransplantation. Nature Medicine. 31(7). 2161–2173. 4 indexed citations

Böhmig, Georg A., et al.. (2025). Microvascular inflammation in kidney allografts: New directions for patient management. American Journal of Transplantation. 25(7). 1410–1416. 2 indexed citations

Parquin, François, Antoine Roux, Marion Rabant, et al.. (2024). Successful prevention of BK-polyomavirus nephropathy using extracorporeal photopheresis for immunosuppression minimisation following severe BK polyomavirus replication after kidney transplantation in a double lung transplant recipient, a case report. BMC Nephrology. 25(1). 363–363. 2 indexed citations

Klein, Amanda, Alexandre Loupy, Eric C. Frey, et al.. (2024). Comparing the prognostic performance of iBOX and biopsy-proven acute rejection for long-term kidney graft survival. American Journal of Transplantation. 24(10). 1784–1793. 5 indexed citations

Klein, Amanda, Alexandre Loupy, Mark D. Stegall, et al.. (2023). Qualifying a novel clinical trial endpoint (iBOX) predictive of long-term kidney transplant outcomes. American Journal of Transplantation. 23(10). 1496–1506. 14 indexed citations

Fedrigo, Marny, Gerald J. Berry, Guillaume Coutance, et al.. (2023). Report of the 2022 Banff Heart Concurrent: Focus on non-human leukocyte antigen antibodies in rejection and the pathology of “mixed” rejection. American Journal of Transplantation. 24(4). 533–541. 7 indexed citations

Bonnet, Guillaume, Guillaume Coutance, Olivier Aubert, et al.. (2023). Sudden cardiac death after heart transplantation: a population-based study. EP Europace. 25(5). 3 indexed citations

Mayer, Katharina A., Klemens Budde, Philip F. Halloran, et al.. (2022). Safety, tolerability, and efficacy of monoclonal CD38 antibody felzartamab in late antibody-mediated renal allograft rejection: study protocol for a phase 2 trial. Trials. 23(1). 270–270. 15 indexed citations

Coutance, Guillaume, E. Kransdorf, Olivier Aubert, et al.. (2022). Clinical Prediction Model for Antibody-Mediated Rejection: A Strategy to Minimize Surveillance Endomyocardial Biopsies After Heart Transplantation. Circulation Heart Failure. 15(10). e009923–e009923. 5 indexed citations

10.

Aubert, Olivier, Gillian Divard, Julio Pascual, et al.. (2021). Application of the iBox prognostication system as a surrogate endpoint in the TRANSFORM randomised controlled trial: proof-of-concept study. BMJ Open. 11(10). e052138–e052138. 24 indexed citations

11.

Mannon, Roslyn B., Randall E. Morris, Michaël Abécassis, et al.. (2020). Use of biomarkers to improve immunosuppressive drug development and outcomes in renal organ transplantation: A meeting report. American Journal of Transplantation. 20(6). 1495–1502. 12 indexed citations

12.

Reese, Peter P., Olivier Aubert, Maarten Naesens, et al.. (2020). Assessment of the Utility of Kidney Histology as a Basis for Discarding Organs in the United States: A Comparison of International Transplant Practices and Outcomes. Journal of the American Society of Nephrology. 32(2). 397–409. 49 indexed citations

13.

Bello, Arnaud Del, Gillian Divard, Julie Bellière, et al.. (2019). Anti‐IL‐2R blockers comparing with polyclonal antibodies: Higher risk of rejection without negative mid‐term outcomes after ABO‐incompatible kidney transplantation. Clinical Transplantation. 33(10). e13681–e13681. 5 indexed citations

14.

Bentall, Andrew, Byron H. Smith, Walter D. Park, et al.. (2019). Modeling graft loss in patients with donor-specific antibody at baseline using the Birmingham-Mayo (BirMay) predictor: Implications for clinical trials. American Journal of Transplantation. 19(8). 2274–2283. 3 indexed citations

15.

See, Sarah B., Olivier Aubert, Alexandre Loupy, et al.. (2018). Post-Transplant Natural Antibodies Associate with Kidney Allograft Injury and Reduced Long-Term Survival. Journal of the American Society of Nephrology. 29(6). 1761–1770. 27 indexed citations

16.

Loupy, Alexandre, Olivier Aubert, Babak J. Orandi, et al.. (2017). A MULTIDIMENSIONAL PROGNOSTIC SCORE AND NOMOGRAM TO PREDICT KIDNEY TRANSPLANT SURVIVAL: THE INTEGRATIVE BOX (IBOX) SYSTEM. Transplant International. 30. 55–56. 3 indexed citations

17.

Huyen, J.P. Duong Van, Marion Tible, Arnaud Gay, et al.. (2014). MicroRNAs as non-invasive biomarkers of heart transplant rejection. European Heart Journal. 35(45). 3194–3202. 150 indexed citations

18.

Loupy, Alexandre, Suresh Krishna Ramakrishnan, Bharath Wootla, et al.. (2012). PTH-independent regulation of blood calcium concentration by the calcium-sensing receptor. Journal of Clinical Investigation. 122(9). 3355–3367. 149 indexed citations

19.

Scemla, Anne, Alexandre Loupy, Sophie Candon, et al.. (2010). Incidence of Infectious Complications in Highly Sensitized Renal Transplant Recipients Treated by Rituximab: A Case-Controlled Study. Transplantation. 90(11). 1180–1184. 28 indexed citations

20.

Anglicheau, Dany, Alexandre Loupy, Caroline Suberbielle, et al.. (2007). Posttransplant Prophylactic Intravenous Immunoglobulin in Kidney Transplant Patients at High Immunological Risk: A Pilot Study. American Journal of Transplantation. 7(5). 1185–1192. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact